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The transcriptional coactivator peroxisome proliferator-acti-
vated receptor  coactivator 1 (PGC-1) is a key integrator of
neuromuscular activity in skeletalmuscle. Ectopic expression of
PGC-1 in muscle results in increased mitochondrial number
and function aswell as an increase in oxidative, fatigue-resistant
muscle fibers. Whole body PGC-1 knock-out mice have a very
complex phenotype but do not have a marked skeletal muscle
phenotype. We thus analyzed skeletal muscle-specific PGC-1
knock-outmice to identify a specific role for PGC-1 in skeletal
muscle function. Thesemice exhibit a shift fromoxidative type I
and IIa toward type IIx and IIbmuscle fibers.Moreover, skeletal
muscle-specific PGC-1 knock-out animals have reduced
endurance capacity and exhibit fiber damage and elevated
markers of inflammation following treadmill running. Our data
demonstrate a critical role for PGC-1 in maintenance of nor-
mal fiber type composition and of muscle fiber integrity follow-
ing exertion.
Skeletal muscle has an enormous capacity to adapt to motor
neuron activity. Many changes in gene expression are con-
trolled by motor neuron-induced calcium signaling (1–3). The
transcriptional coactivator peroxisome proliferator-activated
receptor  coactivator 1 (PGC-1)3 is at the nexus of this
signaling and subsequently regulates the expression of gene
programs needed for skeletal muscle adaptations to increased
work load (4, 5). By coactivating the myocyte enhancer factor 2
members MEF2C and MEF2D, PGC-1 potently drives tran-
scription ofmyofibrillar genes typical of oxidativemuscle fibers
(6). Interestingly,MEF2 and PGC-1 also control PGC-1 gene
transcription in an autoregulatory loop (7, 8). Metabolic genes,
including those responsible for mitochondrial oxidative phos-
phorylation, are induced by a transcriptional cascade with
coactivation of the estrogen-related receptor  (ERR, official
nomenclatureNR3B1), the nuclear respiratory factor 2 (NRF-2,
alternatively called GA-binding protein, GABP), and the
nuclear respiratory factor 1 (NRF-1) by PGC-1 and subse-
quent increase in the levels of mitochondrial transcription fac-
tor A (TFAM) and mitochondrial transcription specificity fac-
tors TFB1M and TFB2M (9–13). Recently, we have found that
activity-induced remodeling of the postsynaptic side of neuro-
muscular junctions involves a complex between PGC-1,
GABP, and host cell factor that assembles upon phosphoryla-
tion of PGC-1 and GABP in post-synaptic nuclei (14).
Data obtained frommuscle-specific PGC-1 transgenic ani-
mals underline the importance of PGC-1 in skeletal muscle in
vivo (6). These mice have increased number and function of
mitochondria accompanied by a higher number of type IIa and
type I oxidative, slow twitch, high endurance muscle fibers (6).
Furthermore, even in the absence of functional motor nerve
signaling following hind leg denervation, ectopically expressed
PGC-1maintains skeletal muscle function and blunts skeletal
muscle atrophy that normally occurs in the absence of motor
neuron signaling (15). Thus, PGC-1 apparently controls most
if not all of the transcriptional changes induced by motor neu-
ron signaling in skeletal muscle. Surprisingly, whole body
PGC-1 knock-out animals do not exhibit a marked skeletal
muscle phenotype (16). Despite a significant reduction of tran-
scription of several mitochondrial genes, no difference in the
relative numbers of the different fiber types is observed (17).
However, whole body PGC-1 knock-out animals have a dom-
inant central nervous system phenotype that might mask the
effects of loss-of-function of PGC-1 in peripheral tissues (16).
These mice are hyperactive, show circadian abnormalities, and
have constitutively activated AMP-activated kinase in skeletal
muscle, all of which might compensate for the loss of PGC-1
in this tissue (16, 18). In the liver, gluconeogenic and heme
biosynthetic genes are constitutively elevated in whole body
PGC-1 knock-out animals even in the fed state (16). In con-
trast, and as expected from previous studies, fasting induction
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of gluconeogenic and heme biosynthetic genes is severely blunted
in the liver of liver-specific PGC-1 knock-out animals (19).
To clarify the genetic requirement for PGC-1 in skeletal
muscle function without the confounding variables seen in the
whole body knockouts, skeletal muscle-specific PGC-1
knock-out animals (MKOs) were generated.4 Here, we report a
moderate reduction in the number of oxidative type I and type
IIamuscle fibers and exercise capacity in thesemice. Strikingly,
skeletal muscle ofMKOs has a low level of damaged and regen-
erating fibers. This compromised skeletal muscle integrity is
dramatically exacerbated by physical exercise and accompa-
nied by elevated markers of systemic inflammation. Our data
thus highlight the importance of PGC-1 in maintaining
proper function and integrity of skeletal muscle.
EXPERIMENTAL PROCEDURES
Animal Experimentation—Generation of MKOs has been
described elsewhere.4 Mice were held under standard condi-
tions. All experiments and protocolswere performed in accord-
ance with the respective Animal Facility Institutional Animal
Care and Use Committee regulations.
Gene Expression Analysis—Total RNA was isolated from tis-
sues using the TRIzol reagent (Invitrogen) according to the
manufacturer’s instructions. After DNase I digest, 1 g of total
RNA was reverse transcribed and analyzed using Applied Bio-
systems Real-time PCR System 7300 using the Ct method.
Relative gene expression was normalized to 18 S rRNA levels.
Histology—Tissues were dissected, embedded in OCT com-
pound (VWR Scientific), dehydrated, embedded in paraffin,
and sectioned. The sections were subsequently stained with
hematoxylin and eosin. Evans blue dye (1% solution) was intra-
peritoneal injected at a concentration of 1% volume/body-
weight 16 h before the treadmill exercise. Mice were sacrificed
pre- and 30min post-exercise and skeletal muscle frozen histo-
logical sections prepared. Evans blue incorporation was ana-
lyzed by fluorescence microscopy. Evans blue-penetrated mus-
cle fibers and fibers with centrally located nuclei were counted
in 20 randomly chosen sections in blinded fashion and were
normalized by the total number of muscle fibers per field.
Immunofluorescent staining for type I, type Iia, and type IIb
muscle fibers was performed with antibodies against the
respective myosin heavy chains as described (20). The relative
numbers of the different fiber types were quantified by count-
ing 20 sections of each muscle bed (type I, red; type Iia, blue;
type Iix, black; type Iib, green).
Comprehensive Laboratory Animal Monitoring System—
Comprehensive laboratory animal monitoring system
(Columbia Instruments) analysis was performed for four
light and three dark periods after an acclimatization of 2
days. Data about locomotive activity were collected every 48
min on 16 mice simultaneously.
Grip Strength—Grip strength was assessed by an inverted
screen test as described (21). Each mouse was placed on top of
an elevated wire mesh grid, the screen was inverted, and the
animals were timed until release from the grid. A maximum
score of 60 s was given if the animal did not fall.
Treadmill Exercise—For 3 days, animals were acclimatized to
treadmill running (Columbus Instruments) for 5min at a speed
of 10 m/min and on a 0% grade. One day before the treadmill
experiment, animals were injected with a 1% Evans blue dye
solution. The next day, animals ran on a treadmill tilted 10%
uphill starting at a speed of 10 m/min for 5 min. Every subse-
quent 2 min, the speed was increased by 2 m/min until mice
were exhausted or a maximal speed of 46 m/min was reached
(supplemental Fig. S1). Exhaustion was defined as the inability
of the animal to remain on the treadmill despite an air puff
stimulus and mechanical prodding. Running time was meas-
ured and running distance, work, and power calculated. Dis-
tance is a function of time and speed of the treadmill. Work is
calculated as the product of bodyweight (kg), gravity (9.81
m/s2), vertical speed (m/s * angle), and time (s). Power is the
product of bodyweight (kg), gravity (9.81 m/s2), and vertical
speed (m/s * angle).
Determination of TNF Serum Concentration—Serum
tumor necrosis factor  (TNF) was determined from mouse
serum using a QuantikineMouse TNF enzyme-linked immu-
nosorbent assay kit according to the manufacturer’s instruc-
tions (R&D Systems).
Serum Creatine Kinase Assay—Mouse blood was collected
and serum isolated using heparin-coated collection tubes (BD
Biosciences). Serum creatine kinase activity was then deter-
mined with the Creatine Kinase-SL Assay kit according to the
manufacturer’s protocol (Diagnostic Chemicals Limited).
Denervation, Determination of Muscle Mass—Disuse atro-
phy was induced by surgical ablation of the sciatic nerve on one
hind leg as described (15). Muscle mass of the control leg and
the denervated leg was determined 12 days after the surgery.
Statistical Analysis—All results are expressed as means, and
error bars depict standard errors. Two-tailed Student’s t test
was used to determine p values. Statistical significance was
defined as p 0.05. For all experiments, at least 8 mice/group
were used.
4 Handschin, C., Choi, C. S., Chin, S., Kim, S., Kawamori, D., Kurpad, A. J.,
Neubauer, N., Hu, J., Mootha, V. K., Kim, Y.-B., Kulkarni, R. N., Shulman, G. I.,
and Spiegelman, B. M. (2007) J. Clin. Investig. in press.
FIGURE 1. Decreased metabolic gene expression in MKOs. Relative gene
expressionwasmeasured fromcDNAextracted fromgastrocnemius andnor-
malized to 18 S rRNA levels. Bars depictmean values, and error bars represent
standard error. *, p 0.05 between control and MKO animals. PDH, pyruvate
dehydrogenase ; MCAD, medium chain acyl-CoA dehydrogenase; PGAM1,
phosphoglycerate mutase 1; PDC-E2, pyruvate dehydrogenase complex, E2
component; MDH1, malate dehydrogenase 1, NAD (soluble); OXCT1,
3-oxoacid CoA transferase; CKMT2, creatine kinase, mitochondrial 2 (sarcom-
eric); LDHA, lactate dehydrogenase A.
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RESULTS
Muscle-specific Knock-out Animals of PGC-1 Have an
Increased Number of Glycolytic Myofibers—The generation of
the MKOs of PGC-1 and analysis of mRNA and protein
expression have beendescribed elsewhere.4 These animals have
a reduced expression of number of mitochondrial genes (Fig. 1)
thatwere previously found to be ele-
vated in PGC-1muscle transgenic
mice (15). Interestingly, PGC-1
levels are not altered by PGC-1
ablation in skeletalmuscle as a com-
pensatory mechanism (Fig. 1).
Mitochondrial gene expression and
oxidative metabolism are hallmarks
of the slow twitch, oxidative type I
and IIa myofiber (3). Thus, to study
whether the corresponding myofi-
brillar gene expression is also
altered in MKOs compared with
controls, we measured the relative
gene expression levels of the respec-
tive myosin heavy chain (MyHC)
isoforms I, IIa, IIx, and IIb in gastro-
cnemius by semiquantitative real-
time PCR, comparing control to
MKO mice. Transcript levels for
MyHCI andMyHCIIa were lower in
MKOs versus control animals, being
reduced by 47 and 78%, respectively
(Fig. 2A). In contrast, MKOs had
significantly higher expression of
MyHCIIx (22% versus controls)
and MyHCIIb (29% versus con-
trols) (Fig. 2A), indicating a reduc-
tion in oxidative, high endurance
fibers and an increase in fast twitch,
glycolytic fibers in MKOs. These
findings were consistent with histo-
logical analysis of different muscle
beds (Fig. 2B and supplemental Fig.
S1). Type IIa fibers were predomi-
nantly replaced by type IIb fibers in
gastrocnemius, plantaris, and tibia-
lis anterior. In MKO soleus muscle,
a muscle rich in type I and IIa fibers,
type I and type IIa fibers were
reduced by 11 and 45%, respectively,
and a clear increase in type IIb fibers
was observed (10%) (Fig. 2B and
supplemental Fig. S1). In control
animals, type IIb fibers were very
rarely found in soleus (Fig. 2B).
Thus, both in terms of gene expres-
sion and histology of myofibrillar
proteins, skeletal muscles of MKOs
have a higher percentage of the gly-
colytic IIx and IIb fibers at the
apparent expense of a loss of oxida-
tive type I and IIa fibers (Fig. 2 and supplemental Fig. S1). Nota-
bly, the loss in type IIa fibers exceeds the reduction in type I
fibers. In fact, a significant reduction of type I fibers was only
observed in the gastrocnemius and the soleus, whereas the
number of type IIa fibers was lower in all four muscles. Inter-
estingly, muscle-specific PGC-1 transgenic animals show a
FIGURE 2. Fiber-type switching toward increased numbers of glycolytic fibers in MKOs. A, relative gene
expression was measured from cDNA extracted from gastrocnemius and normalized to 18 S rRNA levels.
B, cross-sections of plantaris, tibialis anterior, and soleus were immunostained for myosin heavy chains I (red),
IIa (blue), and IIb (green). Bars depict mean values, and error bars represent standard error. *, p 0.05 between
control and MKO animals.
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greater increase in type IIa than type I fibers (6), thus providing
a mirror image of the data obtained in MKOs.
Reduced Muscle Function and Exercise Capacity in MKOs—
Ectopic expression of PGC-1 in skeletal muscle resulted in a
higher fatigue resistance ex vivo in isolated muscle fibers (6).
Accordingly, PGC-1 levels inmuscle correlate with the degree
of physical activity: PGC-1 transcription is induced by exer-
cise and repressed by disuse (15, 22). To study the impact of
PGC-1 ablation on skeletal muscle
function in intact animals, we
assessed the physical condition of
MKOs and control animals. Moni-
toring of locomotive activity in
comprehensive laboratory animal
monitoring systems revealed that
MKOs have regular circadian
rhythms in terms of physical activity
(Fig. 3A). However, MKOs are
hypoactive compared with control
mice (Fig. 3, A and B). These find-
ings are in stark contrast to the
hyperactive PGC-1 total knock-
out animals (16). Interestingly, the
decrease in physical activity in
MKOs is similar in the light and the
dark period (Fig. 3B). The hyperac-
tivity of PGC-1 total knock-out
mice was predominantly caused by
abnormal activity during the light
period (16). Thus, voluntary physi-
cal activity is uniformly reduced in
the light and dark phases in MKO
mice.
In addition to spontaneous
muscle usage, we challenged con-
trol and MKO animals with invol-
untary physical exercise testing
muscle endurance. First, muscle
grip strength was tested using an
inverted screen. Inverted screen
tests for muscle grip strength pre-
dominantly measure isometric
muscle endurance. Previous anal-
yses showed a decreased perform-
ance of global PGC-1 knock-out
mice in this type of test (21). But
because of the various abnormali-
ties in global PGC-1 knockouts,
we decided to reassess this in the
MKOs. MKO mice showed com-
promised muscle function com-
pared with the control mice in this
assay (Fig. 3C). In the two trials,
MKOs were able to hold on for an
average of 17 and 16 s, respec-
tively, whereas control mice
dropped after 42 and 45 s, respec-
tively (Fig. 3C). Thus, lack of skel-
etal muscle PGC-1 leads to a 60% reduction in grip strength
performance in MKOs. Previously published results of
PGC-1 total knock-out animals in the inverted screen test
(21) can now be conclusively explained by impaired muscle
function.
Muscle endurance with dynamic fiber contractions was
assessed by treadmill running to exhaustion, as an indicator of
maximal muscle capacity. After acclimatization, mice were run
FIGURE 3. Decreased physical activity and impaired muscle function in MKOs. A, circadian patterns of
voluntary locomotive activitywere recorded for four light and three dark periods in comprehensive laboratory
animal monitoring systems by infrared beam breaking. B, average locomotive activity of control mice and
MKOs. C, grip strength tests assessed the ability of control andMKO animals to hold onto an inverted grid wire
mesh.Amaximal scoreof 60 swas assigned tomice thatdidnot fall down. Trial 2was repeated30minafter Trial
1. D–G, treadmill exercise. After acclimatization, mice were run on a treadmill with a 10% slope and increasing
speed to exhaustion. Time (D), distance (E), work (F), and power (G) were calculated from the individual perfor-
mances.Barsdepictmean values, and error bars represent standard error. *,p0.05between control andMKO
animals.
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on a 10% slope with a protocol using increasing speed (supple-
mental Fig. S2) until the animals were unable to remain on the
treadmill despite air puff stimuli and prodding. Control animals
ran roughly 7.5 min (28%) longer than MKOs, an average of
26min and 52 s for the controls versus 19min and 25 s for the
MKOs (Fig. 3D). The difference in running distance was even
bigger because of the running protocol with increasing speed
(Fig. 3E). Whereas MKOs covered
an average distance of 323 meters,
control mice ran 536 meters on
the average (a difference of 40%).
Finally, work and power generated
by control animals were also
higher than those of MKOs (Fig. 3,
F and G). Control mice used energy
equivalent to 1007 J whereas the
average work of MKOs came to 594
J (a difference of 41%). Finally, the
17.3 milliwatts of power of the con-
trol mice are 25% higher than the
13.1 milliwatts of the MKOs. In
summary, all the parameters
obtained from the treadmill run-
ning experiment describing muscle
endurance were significantly lower
for MKOs compared with control
mice. Thus, the decrease in muscle
function in MKOs could consis-
tently be shown in different tests
assessing voluntary physical activity
and isometric and dynamic muscle
endurance. Interestingly, PGC-1
total knock-out animals performed
even worse than MKOs in treadmill
running (21). This might reflect
additional defects in heart function
and the motor neuron system in
whole body PGC-1 knock-out
mice that also contribute to physical
endurance.
Basal and Exercise-induced
Myopathy in MKOs—Muscle con-
traction exerts mechanical stress
on muscle fibers. Excess stress can
lead to muscle damage that is nor-
mally offset by muscle regenera-
tion. As described above, MKOs
have a diminished capacity for
physical movement, both volun-
tary and forced. In hematoxylin
and eosin staining of cross-sec-
tions of quadriceps, a higher num-
ber of muscle fibers with centrally
located nuclei, a hallmark of
regenerating muscle fibers, is
found in MKOs compared with
control mice (Fig. 4A). We thus
checked the expression of various
markers of muscle damage and regeneration to study the
impact of muscle-specific PGC-1 ablation on muscle fiber
integrity. Interestingly, we observed a massive induction of
Pax7 gene expression in MKOs (Fig. 4B), a molecular marker
for satellite cells (23). In the MKOs, myogenin expression
was not significantly decreased. Future studies will address
this discrepancy between the published reciprocal regula-
FIGURE 4. MKOs have damaged muscle fibers. A, hematoxylin and eosin staining of gastrocnemius cross-
sections.Arrowheadspoint tomuscle fiberswith centrally located nuclei. B, relative gene expressionmeasured
from cDNA of gastrocnemius muscle and normalized to 18 S rRNA levels. Pax7, paired box gene 7; MyoD,
myogenic differentiation antigen 1; Myf5, myogenic factor 5; MRF4, muscle regulator factor 4; MyHC, myosin
heavy chain. C, serum creatine kinase levels. Serum creatine kinase activity was determined in sedentary
animals (pre-exercise) and mice that were sacked 30 min after the treadmill exercise (post-exercise). D, Evans
blue dye was intraperitoneal injected andmice sacked 16 h later. Post-exercise animals were analyzed 30min
after completion of the treadmill running. Bars depict mean values, and error bars represent standard
error. *, p  0.05 between control and MKO animals.
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tion between Pax7 and the other muscle regulatory factors in
cell culture (24) and our data in vivo. In addition to Pax7,
transcript levels of MyHC3, normally only observed in
embryonic stages of muscle development, were elevated in
MKOs compared with control animals (Fig. 4B). Together,
these data suggest that muscle fiber regeneration is induced
in MKOs by increased recruitment of satellite cells and the
transient expression of MyHC3 in newly formed muscle
fibers. Elevated markers for cell proliferation and decreased
levels of genes involved in growth arrest support this hypoth-
esis (supplemental Fig. S3). Increased muscle fiber regener-
ation is often a sign of muscle damage in mice, and muscle
damage leads to higher serum creatine kinase levels in the
blood leaking from muscle fibers. We therefore measured
serum creatine kinase activity in pre- and post-exercise con-
trol and MKO animals, respectively. We found a 3-fold
increase in serum creatine kinase in sedentary MKOs com-
pared with controls (Fig. 4C). Creatine kinase levels were
further elevated by exercise in MKOs (Fig. 4C). To estimate
the degree of muscle damage in MKOs, we intraperitoneal
injected Evans blue dye into control and MKO animals pre-
and post-exercise. Evans blue can penetrate damagedmuscle
fibers and is visualized by fluorescent microscopy of histo-
logical sections (e.g. see Ref. 14). The increased staining of
muscle fibers in pre-exercise MKOs versus control animals
(Fig. 4D) indicated that MKOs exhibit low grade muscle
damage, even in the basal state. The number of Evans blue-
positive muscle fibers was clearly increased in MKOs post-
exercise (Fig. 4D). In comparison, control animals have no
visible muscle fiber damage after treadmill running (Fig. 4D).
Thus, skeletal muscle PGC-1 is required in maintaining
muscle fiber integrity in the sedentary state; this is evenmore
so during and following physical exertion.
Increased Inflammatory Response in Sedentary and Exercised
MKOs—Many different mechanisms could be involved in
themuscle damage observed inMKOs. Idiopathic inflamma-
tory myopathies are well described disease pathologies in
human patients, and TNF has been causally implicated in
this process (25). We previously noted increased expression
of different inflammatory markers in MKO skeletal muscle
in a non-exercised state, including elevated mRNA levels for
interleukin 6 and TNF.4 In addition, circulating interleukin
6 levels in the blood were elevated in MKOs compared with
controls, but we did not see a significant difference in circu-
lating TNF levels in the non-exercised context. To investi-
gate whether elevation of TNF could be involved in the
increase in muscle damage post-exercise, we measured gene
expression levels and circulating concentrations of TNF in
mice after treadmill running. In MKOs, TNF gene expres-
sion was higher both pre- and post-exercise compared with
control mice4 (Fig. 5A). Remarkably, transcript levels of
TNF were massively increased in exercised MKOs com-
pared with pre-exercised MKOs, whereas no change in
TNF expression was observed in control mice before and
after physical activity (Fig. 5A). This increase in gene expres-
sion was paralleled by a marked rise in circulating TNF in
the blood of MKOs (Fig. 5B). In fact, in sedentary MKOs and
sedentary or exercised control animals, circulating TNF
levels were below the detection limit of our assay and we
could only detect circulating TNF in exercised MKOs.
Thus, increased cytokine levels, in particular those for TNF
in MKOs, likely contribute to fiber damage by inducing an
inflammatory myopathy.
DISCUSSION
Gain-of-function studies in vitro and in vivo established the
importance of PGC-1 in skeletal muscle. Unfortunately,
the complex phenotype of the whole body knockout of
PGC-1 that included hyperactivity confounded, to a great
extent, analysis of skeletal muscle structure and function in
these animals. In the skeletal muscle-specific PGC-1
knock-out animal model studied here, we now conclusively
show that PGC-1 is required for the maintenance of a nor-
mal number of oxidative type I and type IIa muscle fibers.
Accordingly, PGC-1MKOmice are not able tomatch phys-
ical performance of control animals. This was shown for vol-
untary physical activity, forced isometric muscle endurance
in grip strength tests, and dynamic muscle endurance in
FIGURE 5. Increased expression of TNF in MKO skeletal muscle. A, rela-
tive gene expression of TNF normalized to 18 S rRNA levels in control and
MKO animals that were sedentary (pre-exercise) or exercised (post-exercise),
respectively. B, circulating TNF concentration in control and MKO animals
that were sedentary (pre-exercise) or exercised (post-exercise), respectively.
n.d., not detectable. Bars depict mean values, and error bars represent stand-
ard error. *, p 0.05 between control and MKO animals.
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treadmill running. In addition to their distinct functions,
PGC-1 and PGC-1 share common protein binding part-
ners and the regulation of certain gene programs in skeletal
muscle (4, 5). It is thus conceivable that PGC-1 could at
least partially compensate for the lack of PGC-1. However,
no compensatory regulation of PGC-1 gene expression in
skeletal muscle of MKOs was observed.
A surprising finding was that mice with a specific ablation
of PGC-1 in skeletal muscle have increased signs of muscle
fiber damage and regeneration. Under basal conditions, this
damage does not lead to reducedmuscle weight (supplemen-
tal Fig. S4A). Despite the protection observed in PGC-1
muscle transgenic animals against denervation-induced
muscle atrophy, MKOs show no increased propensity for
disuse-mediated muscle atrophy (supplemental Fig. S4A).
Accordingly, expression of atrogenes that control muscle
atrophy is not elevated (supplemental Fig. S4B). Interest-
ingly, the muscle injury inMKOs is dramatically exacerbated
by physical activity. Different factors could contribute to the
muscle pathology in MKOs. First, these animals have a
reduction in mitochondrial gene expression. Mitochondrial
dysfunction is associated with muscle damage in Duchenne
muscular dystrophy (26, 27). Second, reactive oxygen species
detoxification is crucially regulated by PGC-1 (28) and the
levels of a number of reactive oxygen species detoxification
genes are reduced inMKOs, including superoxide dismutase
1, superoxide dismutase 2, adenine nucleotide transporter,
and glutathione peroxidase 1 (14). Reactive oxygen species
cause membrane and protein modifications and have been
causally linked to muscle damage (29). In addition, we
recently found that PGC-1 regulates the gene program
involved in postsynaptic neuromuscular junction plasticity
(14). MKOs have a lower number of acetylcholine clusters on
muscle fiber membranes (14) and thus might be insuffi-
ciently innervated. Finally, systemic inflammation, acute and
chronic, is a strong promoter of skeletal muscle wasting. In
MKOs, we observed increased levels of circulating cytokines
interleukin 6 and TNF. In particular, the rise in plasmaTNF
levels paralleled the dramatic increase in muscle fiber damage
post-exercise. TNF is known to cause inflammatory myopa-
thies in rodent models and human patients (30, 31). Our
hypothesis that increased systemic inflammation in MKOs
might contribute to the myopathy is supported by other phys-
iological and behavioral abnormalities in these mice. The
decrease in body weight and fat mass, reduced physical activity,
skeletal muscle damage, increased body temperature and basal
metabolic rate, and diminished food intake4 are compatible
with symptoms observed in animalmodels and human patients
suffering from chronic inflammation.
In summary, our findings both confirm data obtained from
gain-of-function experimental models and provide novel, sur-
prising insights into the function of PGC-1 in skeletal muscle.
The results highlight the central role for PGC-1 to integrate
motor neuron input and regulate gene programs involved in
oxidative fiber-type determination andmuscle fiber endurance.
Furthermore, our data show that PGC-1 is important for
maintaining skeletal muscle fiber integrity, especially after
physical stress. The observation of inflammatorymyopathy and
overall signs of chronic inflammation inMKOs open novel ave-
nues in our understanding of these devastating muscle diseases
and might result in alternative ways of preventing and treating
skeletal muscle dysfunctions.
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SUPPLEMENTAL FIGURES 
 
Supplemental Fig. S1. Fiber-type switch towards glycolytic fibers in MKOs. The relative number of 
muscle fibers were quantified by counting type I (red color), type IIa (blue color), type IIx (unstained, 
black color) and type IIb fibers (green color) in twenty histological sections of gastrocnemius (panel A), 
plantaris (panel B), tibialis anterior (panel C) and soleus (panel D). *p<0.05 between control and MKO 
animals. 
 
Supplemental Fig. S2. Treadmill running protocol. Control and MKO mice were run on a treadmill 
with increment increase in speed. Control mice performed significantly better than MKOs. 
 
Supplemental Fig. S3. Increased expression of markers for cell proliferation in PGC-1α MKOs. 
Relative gene expression from pooled mRNA of the gastrocnemius of 6 mice was analyzed by real-time 
PCR and normalized to 18S rRNA levels. Abbreviations: P/CAF: p300/CBP-associated factor; GST1: G1 
to S phase transition 1; UBE2: ubiquitine-conjugating enzyme E2 variant 2; MAPRE3: microtubule-
associated protein RP/EB Family Member 3; APC5: anaphase promoting complex subunit 5; PCNA: 
proliferating cell nuclear antigen; GADD45: growth arrest and DNA damage-inducible gene b; RBB4: 
retinoblastoma binding protein 4. 
 
Supplemental Fig. S4. No exacerbation of muscle atrophy by PGC-1α knockout. A, Relative gene 
expression of cDNA from gastrocnemius muscle and normalized to 18S rRNA levels. Abbreviations: 
IGF-1, insulin-like growth factor 1; MuRF-1, muscle-specific ring finger protein 1. B, Muscle weights 
from innervated and denervated hind legs. Disuse-mediated muscle atrophy was induced by surgical 
ablation of the sciatic nerve to one hind leg. Muscle mass was determined 12 days after hind leg 
denervation. Bars depict mean values and error bars represent standard error. *p<0.05 between control 
and MKO animals. 
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